Joost Peerbooms

30 Chapter 2 REFERENCES 1. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999; 14: 529-35. 2. Anitua E, Zalduendo M, Troya M, et al. Leukocyte inclusion within a platelet rich plasma- derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015; 10(3): e0121713. 3. Anitua E, Zalduendo M, Alkhraisat M, et al. Release kinetics of platelet-derived and plasma- derived growth factors from autologous plasma rich in growth factors. Ann Anat. 2013; 195(5): 461-66. 4. Assirelli E, Filardo G, Mariani E, et al. Effect of two different preparations of platelet-rich plasma on synoviocytes. Knee Surg Sports Traumatol Arthrosc. 2015; 23(9): 2690-2703. 5. Braun H, Kim H, Chu C, et al. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014; 42(5): 1204-10. 6. Carlson N, Roach R. Platelet-rich plasma-clinical applications in dentistry. J Am Dent Assoc. 2002; 133: 1383-86. 7. Castillo T, Pouliot M, Kim H, et al. Comparison of growth factor and platelet concentration fromcommercial platelet-rich plasma separation systems. Am J SportsMed. 2011; 39: 266-71. 8. Cavallo C, Filardo G, Mariani E, et al. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg [Am]. 2014; 96(5): 423-29. 9. Davis V, Abukabda A, Radio N, et al. Platelet-rich preparations to improve healing, part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria. J Oral Implantol. 2014; 40(4): 511-21. 10. Denapoli P, Stilhano R, Ingham S, et al. Platelet-rich plasma in a murine model: leukocytes, growth factors, Flt-1, and muscle healing. Am J Sports Med. 2016; 44(8): 1962-71. 11. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014; 7(4): 189-97. 12. Dohan Ehrenfest D, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009; 27: 158-67. 13. Dragoo J, Korotkova T, Wasterlain A, et al. Age-related changes of chondrogenic growth factors in platelet-rich plasma. Oper Tech Orthop. 2012; 22(2): 49-55. 14. Dupley L, Charalambous CP. Platelet-richplasma injections as a treatment for refractory patellar tendinosis: a meta-analysis of randomised trials. Knee Surg Relat Res. 2017; 29(3): 165-71. 15. Engebretsen L, Steffen K, Alsousou J, et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010; 44(15): 1072-81. 16. Evanson J, Guyton M, Oliver DL, et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil Med. 2014; 179(7): 799-805. 17. Everhart J, Cole D, Sojka J, et al. Treatment options for patellar tendinopathy: a systematic review. Arthroscopy. 2017; 33(4): 861-72.